Investigation Overview
February 7, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Catabasis Pharmaceuticals Inc (NASDAQ:CATB) shares over potential securities laws violations by Catabasis Pharmaceuticals Inc and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of ...
You must register (for free) or login to view the entire investigation.